October 17, 2007 - CryoCor, Inc., a medical device company focused on the treatment of cardiac arrhythmias, announced today that CryoCath Technologies Inc. has filed a lawsuit against CryoCor in the United States District Court for the District of Delaware alleging that CryoCor infringes several of CryoCath’s U.S. patents.
The FLAIR Endovascular Stent Graft treats stenoses (narrowing) at the venous anastomosis of synthetic arteriovenous (AV) grafts in hemodialysis patients to increase blood flow.
October 17, 2007 - After a three-week trial, a jury rendered a verdict of "willful" patent infringement in a dispute filed against CHF Technologies, Inc., d/b/a BioVentrix, after Chase Medical sued BioVentrix alleging its Blue Egg Sizer, a hollow, blue silicone device used to guide surgeons in surgically resizing the heart, infringed patents held by Chase.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The Toshiba Aquilion CT line’s product platform design reportedly allows for all customers to benefit from Toshiba’s ...
October 17, 2007 — The first trial to test whether medicated, drug-eluting (dispensing), stents can benefit patients who ...
Agfa HealthCare’s DX-S reportedly fills the gap in the current range of Digital Radiography Solutions by providing a ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 17, 2007 – Siemens Medical Solutions today announced that it recently received FDA 510(k) clearance for a 1.5 ...
The FDA gave ZOLL Medical Corp., a manufacturer of resuscitation devices and related software solutions, clearance to market and sell the ZOLL AED Pro with See-Thru CPR technology, which is designed to help minimize interruptions in CPR. ZOLL aims to comply with a key recommendation of the American Heart Association’s Guidelines for Advanced Cardiac Life Support.
October 17, 2007 - Compared to bare metal stents, in patients with acute myocardial infarction, sirolimus-eluting stent ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Building on the foundation of GE Healthcare’s CT platform, the LightSpeed VCT XT is reportedly capable of capturing ...
October 16, 2007 - Abiomed Inc. will be presenting clinical data on Impella 2.5 percutaneous Ventricular Assist Device ...
Safe medication administration at the hospital bedside is not simply a matter of a nurse handing out the right meds at the right time and to the right patient, of course. Today, the practice is a cooperative effort between the nursing staff and the pharmacy working to maximize the benefits of information technology solutions, such as bar coding and wireless.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 16, 2007 — In response to Medtronic’s decision to voluntarily suspend its Sprint Fidelis defibrillation leads, the Heart Rhythm Society (HRS) made a statement to underscore the importance of the society’s task force recommendations for the surveillance, analysis and performance reporting of pacemakers and implantable cardioverter defibrillators (ICDs).
October 16, 2007 - MIV Therapeutics Inc., a developer of coatings and drug delivery systems for cardiovascular stents ...
Despite advances in our understanding of the pathophysiology of pain and the pharmacology of analgesic drugs, as well as increasing emphasis on adequate pain management [1], pain control remains inadequate in hospitalized patients.
October 16, 2007
